nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0932	0.0932	CbGpPWpGaD
Acebutolol—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0467	0.0467	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0431	0.0431	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0422	0.0422	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0368	0.0368	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.036	0.036	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0357	0.0357	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0349	0.0349	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0332	0.0332	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0325	0.0325	CbGpPWpGaD
Acebutolol—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0324	0.0324	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0309	0.0309	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0302	0.0302	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.03	0.03	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0293	0.0293	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0279	0.0279	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0273	0.0273	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0233	0.0233	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0228	0.0228	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0196	0.0196	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.0194	0.0194	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0191	0.0191	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.016	0.016	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0155	0.0155	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.0127	0.0127	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0101	0.0101	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0071	0.0071	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00709	0.00709	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00694	0.00694	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00689	0.00689	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00674	0.00674	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00642	0.00642	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00628	0.00628	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00608	0.00608	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00595	0.00595	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0059	0.0059	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00577	0.00577	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00575	0.00575	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0055	0.0055	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00544	0.00544	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00538	0.00538	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00463	0.00463	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00453	0.00453	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00449	0.00449	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00449	0.00449	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0044	0.0044	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00439	0.00439	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00419	0.00419	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00409	0.00409	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00394	0.00394	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00385	0.00385	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00377	0.00377	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00293	0.00293	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00292	0.00292	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00287	0.00287	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00262	0.00262	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00256	0.00256	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00254	0.00254	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00248	0.00248	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00238	0.00238	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00237	0.00237	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00232	0.00232	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00231	0.00231	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00231	0.00231	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00231	0.00231	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00226	0.00226	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00217	0.00217	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00215	0.00215	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0021	0.0021	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00171	0.00171	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00166	0.00166	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00162	0.00162	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0015	0.0015	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00147	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.0014	0.0014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00137	0.00137	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00136	0.00136	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00133	0.00133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00127	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00124	0.00124	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000889	0.000889	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000869	0.000869	CbGpPWpGaD
